Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Kyung Nam Pharm Co Ltd
Inventory
Kyung Nam Pharm Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
Inventory
₩12B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
Yuhan Corp
KRX:000100
|
Inventory
₩337.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Inventory
₩104B
|
CAGR 3-Years
14%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Inventory
₩319.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Inventory
₩47.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Inventory
₩22.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Kyung Nam Pharm Co Ltd
Glance View
Kyungnam Pharm Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Uiryeong-Gun, Gyeongsangnam-Do. The company went IPO on 2001-11-06. The firm's product portfolio consists of vitamin products, placenta products, health food products and general pharmaceuticals. The firm provides vitamin products under the brand name LEMONA. The company supplies health food products such as lactobacillus products through convenient stores and marts. The placenta products include human placenta related injections and drinks. The general pharmaceuticals include athlete foot therapeutic agents, inflammatory drugs, cold remedies, multi-nutrients and others.
See Also
What is Kyung Nam Pharm Co Ltd's Inventory?
Inventory
12B
KRW
Based on the financial report for Sep 30, 2025, Kyung Nam Pharm Co Ltd's Inventory amounts to 12B KRW.
What is Kyung Nam Pharm Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
6%
Over the last year, the Inventory growth was 6%. The average annual Inventory growth rates for Kyung Nam Pharm Co Ltd have been -7% over the past three years , 4% over the past five years , and 6% over the past ten years .
